JPH06500104A - ロペラミド化合物の固体経口剤形を処方するための方法 - Google Patents

ロペラミド化合物の固体経口剤形を処方するための方法

Info

Publication number
JPH06500104A
JPH06500104A JP3514470A JP51447091A JPH06500104A JP H06500104 A JPH06500104 A JP H06500104A JP 3514470 A JP3514470 A JP 3514470A JP 51447091 A JP51447091 A JP 51447091A JP H06500104 A JPH06500104 A JP H06500104A
Authority
JP
Japan
Prior art keywords
loperamide
dosage form
solid oral
compound
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3514470A
Other languages
English (en)
Japanese (ja)
Inventor
バロン，ダニエル　ルイス
チャプラ，フランシス　バーナード
デニー，ショーン　アラン
Original Assignee
ザ、プロクター、エンド、ギャンブル、カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ、プロクター、エンド、ギャンブル、カンパニー filed Critical ザ、プロクター、エンド、ギャンブル、カンパニー
Publication of JPH06500104A publication Critical patent/JPH06500104A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP3514470A 1990-08-09 1991-07-29 ロペラミド化合物の固体経口剤形を処方するための方法 Pending JPH06500104A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56501090A 1990-08-09 1990-08-09
US565,010 1990-08-09

Publications (1)

Publication Number Publication Date
JPH06500104A true JPH06500104A (ja) 1994-01-06

Family

ID=24256836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3514470A Pending JPH06500104A (ja) 1990-08-09 1991-07-29 ロペラミド化合物の固体経口剤形を処方するための方法

Country Status (9)

Country Link
EP (1) EP0542879A1 (fi)
JP (1) JPH06500104A (fi)
AU (1) AU661972B2 (fi)
CA (1) CA2088273C (fi)
FI (1) FI930536A (fi)
IE (1) IE912815A1 (fi)
NZ (1) NZ239308A (fi)
PT (1) PT98612A (fi)
WO (1) WO1992002223A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117834A1 (en) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Solid dispersions of a basic drug compound and a polymer containing acidic groups
US10508373B2 (en) 2016-05-13 2019-12-17 Nike, Inc. Embroidered article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332236C (en) * 1985-10-11 1994-10-04 Lourens Wals –,-–-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide, n-oxides
DE3906779A1 (de) * 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament

Also Published As

Publication number Publication date
FI930536A0 (fi) 1993-02-08
AU8440091A (en) 1992-03-02
AU661972B2 (en) 1995-08-17
IE912815A1 (en) 1992-02-12
CA2088273A1 (en) 1992-02-10
FI930536A (fi) 1993-02-08
CA2088273C (en) 1996-05-14
NZ239308A (en) 1994-04-27
EP0542879A1 (en) 1993-05-26
WO1992002223A1 (en) 1992-02-20
PT98612A (pt) 1992-06-30

Similar Documents

Publication Publication Date Title
CN102946869B (zh) γ-羟基丁酸的速释制剂及剂型
EP0290168B1 (en) Ibuprofen sustained release matrix and process
EP0305051B1 (en) Orally sustained-release acetaminophen formulation and process to obtain it
JP3045924B2 (ja) 放出が調整された経口薬剤調合物
EP3509581B1 (en) Formulations of (r)-2-amino-3-phenylpropyl carbamate
ES2205000T5 (es) Composición farmacéutica que contiene irbesartán
FI87424C (fi) Foerfarande foer framstaellning av fasta nifedipinpreparat, som biologiskt laett kan tillgodogoeras och som har en foerdroejd effekt
JPH0122245B2 (fi)
JP2509226B2 (ja) ニトロフラントイン投薬型
JPH0251402B2 (fi)
JPH07558B2 (ja) モピダモール製剤
JP4443119B2 (ja) モダフィニルを含んで成る固体製剤
CN1482903A (zh) 含有那格列奈的制剂
ZA200309289B (en) Oxcarbazepine dosage forms.
AU748359B2 (en) Controlled-release formulations
WO2011010324A1 (en) Oral pharmaceutical composition of rasagiline and process for preparing thereof
HUT74477A (en) Film coated tablet of paracetamol and domperidone
WO2009084036A2 (en) Composition for treatment of viral infections
JPH06500104A (ja) ロペラミド化合物の固体経口剤形を処方するための方法
WO2007141806A1 (en) Pharmaceutical formulations comprising oxcarbazepine and methods thereof
JP2000516601A (ja) 水溶性化合物及びセルロースを含有する粒状物
JP6461142B2 (ja) イソニアジドの顆粒およびリファペンチンの顆粒を含むコーティング錠の形態の抗結核性の安定な医薬組成物ならびにその製造方法
CN1771915A (zh) 一种用于治疗儿童感冒的氨酚麻美口腔崩解片及制备方法
JPH0899875A (ja) ゲンフィブロジル含有製剤組成物およびその製造法
WO2021076066A1 (en) Oral formulations comprising sitagliptin hci monohydrate with improved pharmaceutical characteristics